Ovcon 35 Information
What's inside Ovcon 35
Ovcon 35 Active Ingredients: ethinyl estradiol, norethindrone, details.| Ovcon 35 Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Ovcon 35 35 mcg-0.4 mg | tablet | oral | 1.0 each | OTC |
| Ovcon 35 35 mcg-0.4 mg | tablet | oral | 1.0 each | OTC |
Recent Ovcon 35 Side Effects
Posted by aliflo about 1 year ago
For me, it seems I have been experiencing depression, weight gain and an increace in facial hair. I have only been on it for...
Ovcon 35 in the News
Warner Chilcott Announces Settlement of Remaining Class Action ... - CNNMoney.com
... a tentative settlement to conclude the one remaining antitrust lawsuit involving one of the Company's combined hormonal contraceptives, Ovcon 35. ...
Thu Nov 08 17:06:54 -0500 2007
Warner Chilcott Reports Operating Results for the Quarter Ended ... - CNNMoney.com
The decline in OVCON revenue was primarily due to the introduction of generic versions of OVCON 35 beginning in late October 2006, which led to an 88.3% ...
Fri Nov 09 07:07:30 -0500 2007
JSE extends gains as banks climb - Mail & Guardian Online
... Aveng increased R2,01, or 3,09%, to R67, while Raubex Group grew two rand, or 5,56%, to R38 and Wilson Bayly Holmes-Ovcon pocketed R5,85, or 4,64%, ...
Fri Oct 26 04:11:29 -0400 2007
Ovcon 35 Chemical Information
ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)
norethindrone - The acetate salt form of norethindrone, a synthetic progestational substance with some anabolic, estrogenic, and androgenic properties. Norethindrone binds to the progesterone intracellular receptors in the reproductive system and the resultant activated complex interacts with specific DNA sites. This leads to an alteration in protein synthesis and results in an inhibition of LH release. Consequently, it inhibits ovulation and changes the normal cycle of cervical mucus and endometrium.
Ovcon 35 RSS Feed
